-
1Academic Journal
Authors: Gubergrits, N. B., Dyadyik, O. О., Bieliaieva, N. V., Fomenko, P. G., Chyrkov, Yu. E., Shpak, S. O.
Source: Modern Gastroenterology; № 1 (2019); 59-70
Современная гастроэнтерология; № 1 (2019); 59-70
Сучасна гастроентерологія; № 1 (2019); 59-70Subject Terms: фокальная нодулярная гиперплазия печени, портальная гипертензия, нецирротический портальный фиброз, тромбоз портальной вены, внепеченочная обструкции портальной вены, диагностика, лечение, фокальна нодулярна гіперплазія печінки, портальна гіпертензія, нециротичний портальний фіброз, тромбоз портальної вени, позапечінкова обструкція портальної вени, діагностика, лікування, focal nodular hyperplasia, portal hypertension, non-cirrhotic portal fibrosis, thrombosis portal vein, extra-hepatic portal venous obstruction, diagnostics, treatment, 3. Good health
File Description: application/pdf
Access URL: http://sgastro.com.ua/article/view/159784
-
2Academic Journal
Authors: G. B. Sagoyan, T. V. Shamanskaya, D. Yu. Kachanov, T. N. Galyan, A. V. Filin, M. A. Rakov, E. V. Feoktistova, Yu. N. Likar, S. R. Varfolomeeva, Г. Б. Сагоян, Т. В. Шаманская, Д. Ю. Качанов, Т. Н. Галян, А. В. Филин, М. А. Раков, Е. В. Феоктистова, Ю. Н. Ликарь, С. Р. Варфоломеева
Source: Russian Journal of Pediatric Hematology and Oncology; Том 6, № 3 (2019); 94-102 ; Российский журнал детской гематологии и онкологии (РЖДГиО); Том 6, № 3 (2019); 94-102 ; 2413-5496 ; 2311-1267 ; 10.21682/2311-1267-2019-6-3
Subject Terms: фокальная нодулярная гиперплазия печени, children, autologous hematopoietic stem cell transplantation, late complications, focal nodular liver hyperplasia, дети, аутологичная трансплантация гемопоэтических стволовых клеток, поздние осложнения
File Description: application/pdf
Relation: https://journal.nodgo.org/jour/article/view/534/500; Maris J.M. Recent advances in neuroblastoma. N Engl J Med 2010;362(23):2202–11. doi:10.1056/NEJMra0804577.; Goodman M.S., Gurney J.G., Smith M.A., Olshan A.F. Sympathetic nervous system tumors. In: Ries L.A.G., Smith M.A., Gurney J.G., Linet M., Tamra T., Young J.L. Jr, Bunin G.R., eds. Cancer incidence and survival among children and adolescents: United States SEER Program 1975–1995. National Cancer Institute, SEER Program. Bethesda, MD, 1999. Pp. 65–72.; Spix C., Pastore G., Sankila R., Stiller C.A., Steliarova-Foucher E. Neuroblastoma incidence and survival in European children (1978–1997): report from the Automated Childhood Cancer Information System project. Eur J Cancer 2006;42(13):2081–91. doi:10.1016/j.ejca.2006.05.008.; Matthay K.K., Maris J.M., Schleiermacher G., Nakagawara A., Mackall C.L., Diller L., Weiss W.A. Neuroblastoma. Nat Rev Dis Primers 2016;2:16078. doi:10.1038/nrdp.2016.78.; Matthay K.K., Villablanca J.G., Seeger R.C., Stram D.O., Harris R.E., Ramsay N.K., Swift P., Shimada H., Black C.T., Brodeur G.M., Gerbing R.B., Reynolds C.P. Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. N Engl J Med 1999;341:1165–73. doi:10.1056/NEJM199910143411601.; Laino M.E., Monti S., Klimstra D.S., Tang L.H., Mannelli L. Treatment-related Focal Nodular Hyperplasia Mimicking Liver Metastases. J Pediatr Hematol Oncol 2019;41(2):138–9. doi:10.1097/ MPH.0000000000001362.; Bouyn C.I., Leclere J., Raimondo G., Le Pointe H.D., Couanet D., Valteau-Couanet D., Hartmann O. Hepatic focal nodular hyperplasia in children previously treated for a solid tumor. Incidence, risk factors, and outcome. Cancer 2003;97:3107–13. doi: 10,1002/cncr.11452.; Kumagai H., Masuda T., Oikawa H., Endo K., Takano T. Focal nodular hyperplasia of the liver: direct evidence of circulatory disturbances. J Gastroenterol Hepatol 2000;15:1344–7. PMID: 11129233.; International Working Party. Terminology of nodular hepatocellular lesions. Hepatology 1995;22:983–93. PMID: 7657307.; Franchi-Abella S., Branchereau S. Benign hepatocellular tumors in children: focal nodular hyperplasia and hepatocellular adenoma. Int J Hepatol 2013; 2013:215064. doi:10.1155/2013/215064.; Stocker J.T., Kamal G.I. Focal nodular hyperplasia of the liver: a study of 21 pediatric cases Cancer 1981;48(2):336–45. PMID: 7237404.; Pillon M., Carucci N.S., Mainardi C., Carraro E., Zuliani M., Chemello L., Calore E., Tumino M., Varotto S., Toffolutti T., Destro R., Gazzola M. V., Alaggio R., Basso G., Messina C. Focal nodular hyperplasia of the liver: an emerging complication of hematopoietic SCT in children. Bone Marrow Transplant 2015;50(3):414–9. doi:10.1038/bmt.2014.276.; Joyner B.L., Goyal R.K., Newman B., Levin T.L. Focal nodular hyperplasia of the liver: a sequela of tumor therapy. Pediatr Radiol 2005;35(12):1234–9. doi:10.1007/s00247-005-1558-8.; Fan C.Q., Crawford J.M. Sinusoidal obstruction syndrome (hepatic veno-occlusive disease). J Clin Exp Hepatol 2014;4(4):332–46. doi:10.1016/j.jceh.2014.10.002.; Masetti R., Colecchia A., Rondelli R., Martoni A., Vendemini F., Biagi C., Prete A., Festi D., Lima M., Pession A. Benign hepatic nodular lesions after treatment for childhood cancer. J Pediatr Gastroenterol Nutr 2013;56(2):151–5. doi:10.1097/MPG.0b013e31826f7660.; Berthold F., Ernst A., Hero B., Klingebiel T., Kremens B., Schilling F. H., Simon T. Long-term outcomes of the GPOH NB97 trial for children with high-risk neuroblastoma comparing high-dose chemotherapy with autologous stem cell transplantation and oral chemotherapy as consolidation. Br J Cancer 2018;119(3):282–90. doi:10.1038/s41416-018-0169-8.; Elzembely M.M., Dahlberg A.E., Pinto N., Leger K.J., Chow E.J., Park J.R., Carpenter P.A., Baker K.S. Late effects in high-risk neuroblastoma survivors treated with high-dose chemotherapy and stem cell rescue. Pediatr Blood Cancer 2019;66(1):e27421. doi:10.1002/pbc.27421.; Benz-Bohm G., Hero B., Gossmann A., Simon T., Körber F., Berthold F. Focal nodular hyperplasia of the liver in longterm survivors of neuroblastoma: how much diagnostic imaging is necessary? Eur J Radiol 2010;74(3):e1–5. doi:10.1016/j.ejrad.2009.03.011.; Bartolotta T.V., Midiri M., Scialpi M., Sciarrino E., Galia M., Lagalla R. Focal nodular hyperplasia in normal and fatty liver: a qualitative and quantitative evaluation with contrast-enhanced ultrasound. Eur Radiol 2004;14:583–91. doi:10.1007/s00330-003-2089-z.; Wang W., Chen L.D., Lu M.D., Liu G.J., Shen S.L., Xu Z.F., Xie X.Y., Wang Y., Zhou L.Y. Contrast-enchanced ultrasound features of histologically proven focal nodular hyperplasia: diagnostic performance compared with contrast-encanced CT. Eur Radiol 2013;23(9):2546–54. doi:10.1007/s00330-013-2849-3.; Dill-Macky M.J., Burns P.N., Khalili K., Wilson S.R. Focal hepatic masses: enhancement patterns with SH U 508A and pulse-inversion US. Radiology 2002;222: 1:95–102. doi:10.1148/radiol.2221010092.; Lencioni R., Cioni D., Bartolozzi C. Focal liver lesions, detection, characterization, ablation. Springer Verlag, 2005. ISBN: 3540644644.; Li A.-J., Zhou W.P., Wu M.C. Diagnosis and treatment of hepatic focal nodular hyperplasia: report of 114 cases. Zhonghua Wai Ke Za Zhi (Chinese J Surg) 2006;44(5):321–3. PMID: 16635391.; Mortele K.J., Praet M., Van Vlierberghe H., Kunnen M., Ros P.R. CT and MR imaging findings in focal nodular hyperplasia of the liver: radiologic-pathologic correlation. Am J Roentgenol 2000;175(3):687–92. doi:10.2214/ajr.175.3.1750687.; Seale M.K., Catalano O.A., Saini S., Hahn P.F., Sahani D.V. Hepatobiliary-specific MR contrast agents: role in imaging the liver and biliary tree. Radiographics: a review publication of the Radiological Society of North America 2009;29(6):1725–48. doi:10.1148/rg.296095515.; Sharp S.E., Trout A.T., Weiss B.D., Gelfand M.J. MIBG in Neuroblastoma Diagnostic Imaging and Therapy. Radiographics 2016;36(1):258–78. doi:10.1148/rg.2016150099.; Vik T.A., Pfluger T., Kadota R., Castel V., Tulchinsky M., Farto J.C., Heiba S., Serafini A., Tumeh S., Khutoryansky N., Jacobson A.F. (123) I-mIBG scintigraphy in patients with known or suspected neuroblastoma: Results from a prospective multicenter trial. Pediatr Blood Cancer 2009;52(7):784–90. doi:10.1002/pbc.21932.; Nakajo M., Shapiro B., Copp J., Kalff V., Gross M.D., Sisson J.C., Beierwaltes W.H. The normal and abnormal distribution of the adrenomedullary imaging agent m-[I-131] iodobenzylguanidine (I-131 MIBG) in man: evaluation by scintigraphy. J Nucl Med 1983;24(8):672–82. PMID: 6135764.; Jacobsson H., Hellström P.M., Kogner P., Larsson S.A. Different concentrations of I-123 MIBG and In-111 pentetreotide in the two main liver lobes in children: persisting regional functional differences after birth? Clin Nucl Med 2007;32(1):24–8. doi:10.1097/01.rlu.0000249592.95945.e4.; Kulatunge C.R., Son H. False-positive 123I-MIBG scintigraphy due to multiple focal nodular hyperplasia. Clin Nucl Med 2013;38(12):976–8. doi:10.1097 / RLU.0000000000000234.; https://journal.nodgo.org/jour/article/view/534
-
3Academic Journal
Authors: Z. A. Agaeva, T. S. Avhadov, L. V. Gorbov, E. N. Karanadze, З. А. Агаева, Т. С. Авхадов, Л. В. Горбов, Е. Н. Каранадзе
Source: Medical Visualization; № 1 (2017); 13-19 ; Медицинская визуализация; № 1 (2017); 13-19 ; 2408-9516 ; 1607-0763
Subject Terms: метастазы колоректального рака в печени, liver hemangioma, hepatocellular adenoma of the liver, focal nodular hyperplasia, metastases of colorectal cancer, кавернозная гемангиома печени, гепатоцеллюлярная аденома, фокальная нодулярная гиперплазия печени
File Description: application/pdf
Relation: https://medvis.vidar.ru/jour/article/view/370/358; Агаева З.А. Ультразвуковая эластография сдвиговой волной в дифференциальной диагностике объемных поражений печени. Ультразвуковая и функциональная диагностика. 2014; 6: 21–28.; Степанова, Ю.А., Кармазановский Г.Г. Фокальная нодулярная гиперплазия печени. Причины развития, особенности течения и диагностика у женщин: Материалы I Всероссийской конференции “Проблемы женского здоровья и пути их решения”. Москва, 2007: 45–49.; Weskott H.-P. Контрастная сонография. Бремен; Лондон; Бостон: UNI-MED VerlagAG, 2014. 16 c.; Зубарев А.В. Современная ультразвуковая диагностика: теория и практика. Радиология-Практика. 2008; 5: 4–14.; Лукьянченко А.Б., Медведева Б.М. МРТ в диагностике и дифференциальной диагностике очаговых поражений печени. Вестник РОНЦ им. Н.Н. Блохина РАМН. 2004; 1: 68–72.; Marsh J.I., Li D.K. Hepatic hemangio,a in the presence of fatty infiltration: an atypical sonographic appearance. Gastrointest. Radiol. 1989; 14: 252–264.; Morel D.R., Schwieger I., Hohn L., Terrettaz J., Llull J.B., Cornioley Y.A., Schneider M. Human pharmacokinetics and safety evaluation of SonoVue, a new contrast agent for ultrasound imaging. Invest. Radiol. 2000: 35 (1): 80–85.; Leen E., Ceccotti P., Kalogeropoulou C., Angerson W.J., Moug S.J., Horgan P.G. Prospective multicenter trialevaluating a novel method of characterizing focal liverlesions using contrast-enhanced sonography. Am. J. Roentgenol. 2006; 186 (6): 1551–1559. DOI:10.2214/AJR.05.0138.; Wilson S.R., Burns P.N. An algorithm for the diagnosis of focal liver masses using microbubble contrast-enhanced pulse-inversion sonography. Am. J. Roentgenol. 2006; 186 (5): 1401–1412. DOI:10.2214/AJR.04.1920.; Wilson S.R., Burns P.N. Microbubble contrast enganced ultrasound in body imaging: what role? Radiology. 2010; 257 (1): 24–39. DOI:10.1148/radiol.10091210.; Claudon M., Cosgrove D., Albrecht T., Dietrich C.F., Choi B.I. Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) – update 2008. Ultraschall Med. 2008; 29: 28–44.; Bolondi L., Correas J.M., Lencioni R., Weskott H.P., Piscaglia F. New perspectives for the use if contrastenhanced liver ultrasound in clinical practice. Dig. Liver Dis. 2007; 39 (2): 187– 195. DOI:10.1016/j.dld.2006.08.008.; Quaia E., Degobbis F., Tona G., Mosconi E., Bertolotto M., Pozzi Mucelli R. Differential patterns of contrast enhancement in different focal liver lesions after injection of the microbubble US contrast agent SonoVue. Radiol. Med. 2004; 107 (3): 155–165.; Lampaskis M., Averkiou M. Investigation of the relationship of nonlinear backscattered ultrasound intensity with microbubble concentration at low MI. Ultrasound Med. Biol. 2010; 36 (2): 306–312. DOI:10.1016/j.ultrasmedbio.2009.09.011.; Bauditz J., Schade T., Wermke W. Sonographic diagnosis of hilar cholangiocarcinomas by the use of contrast agents. Ultraschall Med. 2007; 28 (2): 161–167. DOI:10.1055/s-2007-962825.; Ding H., Wang W.P., Huang B.J., Wei R.X., He N.A., Qi Q., Li C.L. Imaging of focal liver lesions: low-mechanicalindex real-time ultrasonography with SonoVue. J. Ultrasound Med. 2005; 24 (3): 285–297.; Dietrich C.F., Schuessler G., Trojan J., Fellbaum C., Ignee A. Differentiation of focal nodular hyperplasia and hepatocellular adenoma by contrast-enhanced ultrasound. Br. J. Radiol. 2005; 78 (932): 704–707. DOI:10.1259/bjr/88181612.; Kinkel K., Lu Y., Both M., Warren R.S., Thoeni R.E. Detection of hepatic metastases from cancers of the gastrointestinal tract by using noninvasive imaging methods (US, CT, MR imaging, PET): a meta-analysis. Radiology. 2002; 224 (3): 748–750. DOI:10.1148/radiol.2243011362.; https://medvis.vidar.ru/jour/article/view/370